Compared to the NAFLD mice group, METTL14-silenced mice exhibited decreased levels of AST, ALT, TC, and TG (P < 0.05, Figure 1E–1H). The gene discussed is METTL14; the disease is metabolic dysfunction-associated steatotic liver disease.